Clinical trial
REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial
NCT00319150 · Queen's University, Other · Terminated
Key facts
| NCT number | NCT00319150 |
|---|---|
| Title | REPEAT Study - Resistance to ErythroPoietin Effectiveness Algorithm Trial |
| Official title | Resistance to ErythroPoietin Effectiveness Algorithm Trial |
| Lead sponsor | Queen's University, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Drug Resistance |
| Intervention type | Drug |
| Interventions | erythropoietin |
| Enrollment | 6 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2009 |
| Completion | Feb 1, 2009 |
| First posted | Apr 27, 2006 |
| Last update posted | Feb 12, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: